Marco Carli Selected Research

Marco Carli Research Topics

4	Schizophrenia (Dementia Praecox) 03/2021 - 01/2017
3	Parkinson Disease (Parkinson's Disease) 06/2022 - 12/2018
3	Bipolar Disorder (Manic Depressive Psychosis) 01/2022 - 01/2017
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 04/2021 - 01/2021
2	Psychotic Disorders (Schizoaffective Disorder) 03/2021 - 12/2018
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2021
1	Borderline Personality Disorder (Personality Disorders, Borderline) 01/2021
1	Mental Disorders (Mental Disorder) 11/2020
1	Pathologic Processes 01/2020
1	Neoplasms (Cancer) 01/2020
1	Pain (Aches) 01/2020
1	Substance-Related Disorders (Drug Abuse) 01/2020
1	Cancer Pain 01/2020
1	Weight Gain 12/2018
1	Agranulocytosis (Granulocytopenia) 12/2018
1	Treatment-Resistant Schizophrenia 12/2018
1	Glioma (Gliomas) 01/2017

3	Clozapine (Clozaril)FDA LinkGeneric 11/2020 - 01/2017
2	Antipsychotic Agents (Antipsychotics)IBA 03/2021 - 11/2020
1	naxagolideIBA 06/2022
1	LithiumIBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	Valproic Acid (Depakote)FDA LinkGeneric 01/2022
1	NeurotoxinsIBA 08/2021
1	Oxidopamine (6 Hydroxydopamine)IBA 08/2021
1	RotenoneIBA 08/2021
1	1-Methyl-4-phenylpyridinium (1 Methyl 4 phenylpyridinium)IBA 08/2021
1	Cocaine (Cocaine HCl)IBA 04/2021
1	Antidepressive Agents (Antidepressants)IBA 01/2021
1	Chlorpromazine (Thorazine)FDA Link 11/2020
1	Dopamine Receptors (Dopamine Receptor)IBA 11/2020
1	Morphine (MS Contin)FDA LinkGeneric 01/2020
1	Opioid Receptors (Opioid Receptor)IBA 01/2020
1	CannabinoidsIBA 01/2020
1	Dronabinol (THC)FDA LinkGeneric 01/2020
1	Opioid Analgesics (Opioids)IBA 01/2020
1	Dopamine (Intropin)FDA LinkGeneric 01/2018
1	5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA 01/2017
1	Phosphotransferases (Kinase)IBA 01/2017
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2017
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2017